Sensei Biotherapeutics (STU:4070) Total Assets : €35.40 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Sensei Biotherapeutics Total Assets?

Sensei Biotherapeutics's Total Assets for the quarter that ended in Mar. 2025 was €35.40 Mil.

During the past 12 months, Sensei Biotherapeutics's average Total Assets Growth Rate was -54.20% per year. During the past 3 years, the average Total Assets Growth Rate was -10.40% per year. During the past 5 years, the average Total Assets Growth Rate was 31.50% per year.

During the past 7 years, Sensei Biotherapeutics's highest 3-Year average Total Assets Growth Rate was 126.70%. The lowest was -10.40%. And the median was 44.30%.

Total Assets is connected with ROA %. Sensei Biotherapeutics's annualized ROA % for the quarter that ended in Mar. 2025 was -64.52%. Total Assets is also linked to Revenue through Asset Turnover. Sensei Biotherapeutics's Asset Turnover for the quarter that ended in Mar. 2025 was 0.00.

Sensei Biotherapeutics Total Assets Historical Data

The historical data trend for Sensei Biotherapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensei Biotherapeutics Total Assets Chart

Sensei Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

17.61

135.60

111.75

68.20

43.32

Sensei Biotherapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Assets	Get a 7-Day Free Trial															61.36	55.55	47.98	43.32	35.40

Sensei Biotherapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sensei Biotherapeutics's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	36.659	+	6.661
	=	43.32

Sensei Biotherapeutics's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2025 )	+	Total Liabilities (Q: Mar. 2025 )
	=	29.588	+	5.815
	=	35.40

Sensei Biotherapeutics (STU:4070) Total Assets Explanation

Total Assets is connected with ROA %.

Sensei Biotherapeutics's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %	=	Net Income (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	-25.396	/	( (43.32	+	35.403)	/ 2 )
	=	-25.396	/	39.3615
	=	-64.52 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sensei Biotherapeutics's Asset Turnover for the quarter that ended in Mar. 2025 is

	Asset Turnover
=	Revenue (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
=	0	/	( (43.32	+	35.403)	/ 2 )
=	0	/	39.3615
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sensei Biotherapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Sensei Biotherapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensei Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensei Biotherapeutics Inc (STU:4070) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SNSE:USA 407:Germany

Address

1405 Research Boulevard, Suite 125, Rockville, MD, USA, 20850

Website

https://www.senseibio.com

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Sensei Biotherapeutics Headlines

No Headlines